Tandem Diabetes Care (Nasdaq:TNDM) shares ticked up after hours today on third-quarter results that topped the consensus ...

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that its third batch of pharm ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...

Bashan declined to reveal how much the company owed creditors, but in its bankruptcy filing in U.S. Bankruptcy Court in ...

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.

The FDA rejected sotagliflozin 5 years ago for the same indication but for the broader population of adults with T1D, due to ...

On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...

Lexicon Pharmaceuticals shares tumbled in premarket trading Friday after a Food and Drug Administration advisory committee's negative vote on the biopharmaceutical company's Zynquista as an adjunct to ...

While an FDA advisory committee saw signals of efficacy for Lexicon Pharmaceuticals’ sotagliflozin, the panel of external ...